Home
>
US Stocks
>
Orchard Therapeutics plc - ADR
Orchard Therapeutics plc - ADR
ORTX

Orchard Therapeutics plc - ADR

$2.0820.91%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
2.09
Today Low/High
2.06 / 2.1
52 Week Low/High
$2.59 / $9.08
Market Cap
$330.98M

Company Details

Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. The company's ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration. In 2018, Orchard acquired GSK's rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Orchard now has one of the deepest and most advanced gene therapy product candidate pipelines in the industry spanning multiple therapeutic areas where the disease burden on children, families and caregivers is immense and current treatment options are limited or do not exist.
Organisation
Orchard Therapeutics plc - ADR
Headquaters
108 Cannon Street, London, United Kingdom
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Orchard Therapeutics plc - ADR share price today

Can Indians buy Orchard Therapeutics plc - ADR shares?

How can I buy Orchard Therapeutics plc - ADR shares from India?

Can Fractional shares of Orchard Therapeutics plc - ADR be purchased?

What are the documents required to start investing in Orchard Therapeutics plc - ADR stocks?

We are a SEBI registered investement advisor